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In the past few decades, prenatal diagnosis of fetal
chromosomal abnormalities has relied on conventional
cytogenetic analysis of cultured amniocytes, chorionic
villi, or fetal blood. In recent years, the clinical validity
of a newer technique, QF-PCR, to detect the common
aneuploidies has been reported by a number of investi-
gators. This technique has the advantage of providing
rapid results for the diagnosis or exclusion of aneu-
ploidy in chromosomes 13, 18, 21, X or Y. It is now
possible to choose standard chromosome analysis or
QF-PCR for the prenatal diagnosis of chromosomal
abnormalities, or to perform both tests, depending on
the clinical indication for testing.
QF-PCR exploits the distribution of STR markers,
2-6bp tandem repeats, across the genome. This DNA
marker is easily amplified by polymerase chain reaction
(PCR) without the problem of differential amplification;
that is, the PCR products for STRs are generally similar
in amount, making analysis easier. An individual inherits
one copy of an STR from each parent, which may or
may not have similar repeat sizes. The number of
repeats in STR markers can be highly variable among
individuals, which make these STRs effective for diagno-
sis and human identification purposes. It has an added
advantage of identifying maternal or paternal origin of
nondysjunction.
The establishment of QF-PCR has been initiated with
the aim of providing rapid prenatal diagnostic service
and to reduce anxiety of patients about their at risk
pregnancies.
For validation, we performed analysis on 100 confirmed
cases of Down syndrome with the markers D21S1435,
D21S11 and D21S1411, whose heterozygosity has been
studied in North Indian population, with heterozygosity
of 70.1%, 83.1% and 93.6% respectively. We observed
100% concordance with the clinical diagnosis as well as
cytogenetic analysis. With these results we extended the
methodology in prenatal services were chromosomal stu-
dies are very common for suspected Down syndrome
pregnancies. However, in addition we included 2 more
markers D21S1411 and D21S1413 for 21 chromosome,
D13S238 and D13S631 for 13 chromosome, D18S391 for
18 chromosome and AMEL, XHPRT, X22 and SRY for
sex chromosomes. Addition of 13, 18 and sex chromo-
somes marker were helpful at drawing conclusive reports
for maternal contaminated samples and simultaneously
to screen for rare aneuploides like 13, 18 trisomy and
Klinefelter syndrome.
The test was offered to the pregnancies with triple test
positive as well as abnormal findings in ultrasonography.
The source of DNA was 3 – 5 ml of amniotic fluid while
in few cases chorionic villi sample. 190 pregnancies were
studied to date, 3 pregnancies (1.6%) were turned to be
Down syndrome positive while rest was negative for Down
syndrome while 1 case was turned out to be homozygous
for all 4 markers of 21chromosome in which we required
additional markers to do reporting. However, karyotying
showed this sample to be negative for Down syndrome.
Rest all the finding was consistent with that of karyotyping
results.
The technique has its own advantage that can utilize the
maternal blood contaminated samples, to add more, low
volume of sample requirement and possibility to do
reporting within 6 – 12 hours. Still we are working to
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record heterozygosity of rest of the 8 markers and to tune
up the marker panel accordingly.
Published: 21 January 2014
doi:10.1186/1755-8166-7-S1-I58
Cite this article as: Agarwal et al.: STR Markers in clinics: a rapid
prenatal diagnosis by quantitative fluorescent-pcr for aneuploidies.
Molecular Cytogenetics 2014 7(Suppl 1):I58.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Agarwal et al. Molecular Cytogenetics 2014, 7(Suppl 1):I58
http://www.molecularcytogenetics.org/content/7/S1/I58
Page 2 of 2
